These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11514686)

  • 21. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes.
    Carlsen KH; Ingjer F; Kirkegaard H; Thyness B
    Scand J Med Sci Sports; 1997 Jun; 7(3):160-5. PubMed ID: 9200320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of exercise performance with inhaled albuterol.
    Bedi JF; Gong H; Horvath SM
    Can J Sport Sci; 1988 Jun; 13(2):144-8. PubMed ID: 3293733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a long- and short-acting beta2-agonist on exercise-induced arterial hypoxemia.
    Stewart IB; Labreche JM; McKenzie DC
    Med Sci Sports Exerc; 2003 Apr; 35(4):603-7. PubMed ID: 12673143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acute inhalation of albuterol on submaximal and maximal VO2 and blood lactate.
    Fleck SJ; Lucia A; Storms WW; Wallach JM; Vint PF; Zimmerman SD
    Int J Sports Med; 1993 Jul; 14(5):239-43. PubMed ID: 8365829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of formoterol inhalation on endurance performance in hypobaric conditions.
    Riiser A; Tjørhom A; Carlsen KH
    Med Sci Sports Exerc; 2006 Dec; 38(12):2132-7. PubMed ID: 17146320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of salbutamol on performance in elite nonasthmatic athletes.
    Meeuwisse WH; McKenzie DC; Hopkins SR; Road JD
    Med Sci Sports Exerc; 1992 Oct; 24(10):1161-6. PubMed ID: 1435165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes.
    Hostrup M; Kalsen A; Auchenberg M; Bangsbo J; Backer V
    Scand J Med Sci Sports; 2016 Jan; 26(1):8-16. PubMed ID: 25077918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The asthmatic athlete: metabolic and ventilatory responses to exercise with and without pre-exercise medication.
    Ienna TM; McKenzie DC
    Int J Sports Med; 1997 Feb; 18(2):142-8. PubMed ID: 9081272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acute and short-term oral salbutamol treatments on maximal power output in non-asthmatic athletes.
    Sanchez AM; Collomp K; Carra J; Borrani F; Coste O; Préfaut C; Candau R
    Eur J Appl Physiol; 2012 Sep; 112(9):3251-8. PubMed ID: 22230921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of caffeine and albuterol on the bronchoconstrictor response to exercise in asthmatic athletes.
    VanHaitsma TA; Mickleborough T; Stager JM; Koceja DM; Lindley MR; Chapman R
    Int J Sports Med; 2010 Apr; 31(4):231-6. PubMed ID: 20148372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial.
    Eckerström F; Rex CE; Maagaard M; Rubak S; Hjortdal VE; Heiberg J
    BMJ Open Sport Exerc Med; 2018; 4(1):e000397. PubMed ID: 30233808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of formoterol on endurance performance in athletes at an ambient temperature of -20 degrees C.
    Tjørhom A; Riiser A; Carlsen KH
    Scand J Med Sci Sports; 2007 Dec; 17(6):628-35. PubMed ID: 17316372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.
    Zügel M; Bizjak DA; Nussbaumer D; Winkert K; Takabayashi K; Kirsten J; Washington M; Treff G; Dreyhaupt J; Steeb L; Diel P; Parr MK; Steinacker JM; Persch H
    Trials; 2021 Dec; 22(1):903. PubMed ID: 34895300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled salbutamol decreases blood ammonia levels during exercise in normal subjects.
    Matthys D; Calders P; Pannier JL
    Eur J Appl Physiol Occup Physiol; 1998 Dec; 79(1):110-3. PubMed ID: 10052670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
    Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
    Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.